{"id":"W4415790827","doi":"10.4103/crst.crst_15_25","title":"Excellence in oncology care (EIOC) consensus guidelines on integrating immunotherapy (IO) in resectable non-small cell lung cancer (NSCLC) for the Middle East and Indian subcontinent","year":2025,"lang":"en","type":"article","venue":"Cancer Research Statistics and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"ASTER","funders":"","keywords":"Pembrolizumab; Lung cancer; Atezolizumab; Immunotherapy; Excellence; Chemotherapy; Adjuvant; Disease; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004845769,0.0002071702,0.0003706755,0.0002762782,0.0002399163,0.00005563303,0.00009240061,0.00009361693,0.00003592408],"category_scores_gemma":[0.00007990689,0.0001346429,0.00004106765,0.000321897,0.000273178,0.00001384765,0.00003929584,0.000264164,2.898002e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00135876,"about_ca_system_score_gemma":0.001394257,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.04061965,"about_ca_topic_score_gemma":0.0488966,"domain_scores_codex":[0.998436,0.0001063451,0.0003946396,0.0004069901,0.0001816735,0.000474319],"domain_scores_gemma":[0.998383,0.0008962154,0.00007130748,0.0002315817,0.0003422293,0.00007562643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01327396,0.0004883009,0.06133511,0.001091921,0.0004625021,0.0002128637,0.02304693,0.0001145722,0.007166116,0.0004264216,0.005278386,0.8871029],"study_design_scores_gemma":[0.1836786,0.02424302,0.1696038,0.02443327,0.0007953807,0.00005144014,0.2070545,0.0464821,0.03782469,0.00127997,0.302305,0.002248235],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8435726,0.1423409,0.0002600318,0.008239803,0.0002854856,0.003683257,0.0009845826,0.000009841085,0.0006235345],"genre_scores_gemma":[0.915326,0.07789249,0.001437714,0.0004302716,0.00008146616,0.002788054,0.0000512209,0.00002516254,0.001967624],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8848547,"threshold_uncertainty_score":0.9684585,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1184238318118911,"score_gpt":0.4289081210910559,"score_spread":0.3104842892791648,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}